Trademark: 90712401
Status Date
Wednesday, October 11, 2023
Filing Date
Friday, May 14, 2021
Published for Opposition
Tuesday, March 1, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Oct 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 11, 2023
Sou Extension 3 Granted
Oct 11, 2023
Sou Extension 3 Filed
Oct 11, 2023
Sou Teas Extension Received
Apr 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 6, 2023
Sou Extension 2 Granted
Apr 6, 2023
Sou Extension 2 Filed
Apr 6, 2023
Sou Teas Extension Received
Oct 17, 2022
Teas Change Of Correspondence Received
Oct 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 7, 2022
Sou Extension 1 Granted
Oct 7, 2022
Sou Extension 1 Filed
Oct 7, 2022
Sou Teas Extension Received
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 24, 2022
Approved For Pub - Principal Register
Jan 24, 2022
Assigned To Examiner
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 16, 2021
New Application Office Supplied Data Entered
May 18, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24